Background Despite advances in early detection and therapies, cancer is still one of the
most common causes of death worldwide. Since each tumor is unique, there is a need to …

Immune checkpoint therapies (ICT) can reinvigorate the effector functions of anti-tumour T
cells, improving cancer patient outcomes. Anti-tumour T cells are initially formed during their …

Background Bladder cancer (BLCA) is the most common malignancy of the urinary tract. On
the other hand, disulfidptosis, a mechanism of disulfide stress-induced cell death, is closely …

The phenomenon of T Cell exhaustion (TEX) entails a progressive deterioration in the
functionality of T cells within the immune system during prolonged conflicts with chronic …

In the past few decades, according to the rapid development of information technology,
artificial intelligence (AI) has also made significant progress in the medical field. Colorectal …

As the most aggressive tumor, the outcome of pancreatic cancer (PACA) has not improved
observably over the last decade. Anatomy-based TNM staging does not exactly identify …

Muscle-invasive urothelial cancer (MUC), characterized by high aggressiveness and
significant heterogeneity, is currently lacking highly precise individualized treatment options …

Background Immune cells are crucial components of the tumor microenvironment (TME) and
regulate cancer cell development. Nevertheless, the clinical implications of immune cell …

To accurately predict the prognosis and further improve the clinical outcomes of bladder
cancer (BLCA), we leveraged large‐scale data to develop and validate a robust signature …

A flexible feature for the long-reigning thermoelectric champion bismuth telluride | Nature
Nanotechnology Skip to main content Thank you for visiting nature.com. You are using a …